PL185858B1 - Związek addycyjny kwasu 4-[(2-n-butylo-5-formylo-1Związek addycyjny kwasu 4-[(2-n-butylo-5-formylo-1H-imidazol-1-ilo)metylo]benzoesowego z wodorosiarcH-imidazol-1-ilo)metylo]benzoesowego z wodorosiarczynem i sposób jego wytwarzaniazynem i sposób jego wytwarzania - Google Patents
Związek addycyjny kwasu 4-[(2-n-butylo-5-formylo-1Związek addycyjny kwasu 4-[(2-n-butylo-5-formylo-1H-imidazol-1-ilo)metylo]benzoesowego z wodorosiarcH-imidazol-1-ilo)metylo]benzoesowego z wodorosiarczynem i sposób jego wytwarzaniazynem i sposób jego wytwarzaniaInfo
- Publication number
- PL185858B1 PL185858B1 PL95317538A PL31753895A PL185858B1 PL 185858 B1 PL185858 B1 PL 185858B1 PL 95317538 A PL95317538 A PL 95317538A PL 31753895 A PL31753895 A PL 31753895A PL 185858 B1 PL185858 B1 PL 185858B1
- Authority
- PL
- Poland
- Prior art keywords
- methyl
- butyl
- imidazol
- benzoic acid
- formyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 26
- QLMGJDCOKQGJKF-UHFFFAOYSA-N 4-[(2-butyl-5-formylimidazol-1-yl)methyl]benzoic acid Chemical compound CCCCC1=NC=C(C=O)N1CC1=CC=C(C(O)=O)C=C1 QLMGJDCOKQGJKF-UHFFFAOYSA-N 0.000 claims abstract description 12
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims abstract description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 7
- 238000002955 isolation Methods 0.000 claims description 6
- UCDIXJKWUCLMJK-UHFFFAOYSA-N 2-bromo-3-propan-2-yloxyprop-2-enal Chemical compound CC(C)OC=C(Br)C=O UCDIXJKWUCLMJK-UHFFFAOYSA-N 0.000 claims description 5
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 claims description 5
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 claims description 5
- 239000002333 angiotensin II receptor antagonist Substances 0.000 claims description 4
- 229940126317 angiotensin II receptor antagonist Drugs 0.000 claims description 4
- RZUOYFGIQVKGKC-UHFFFAOYSA-N 4-[(1-aminopentylideneamino)methyl]benzoic acid Chemical compound CCCCC(=N)NCC1=CC=C(C(O)=O)C=C1 RZUOYFGIQVKGKC-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 159000000000 sodium salts Chemical class 0.000 claims description 3
- 238000003786 synthesis reaction Methods 0.000 claims description 3
- 230000003389 potentiating effect Effects 0.000 claims description 2
- -1 4-carboxyphenyl Chemical group 0.000 claims 3
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000005711 Benzoic acid Substances 0.000 claims 1
- 238000002425 crystallisation Methods 0.000 claims 1
- 230000008025 crystallization Effects 0.000 claims 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 claims 1
- 238000004821 distillation Methods 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000002243 precursor Substances 0.000 claims 1
- 239000002464 receptor antagonist Substances 0.000 claims 1
- 229940044551 receptor antagonist Drugs 0.000 claims 1
- 238000010626 work up procedure Methods 0.000 claims 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 239000000203 mixture Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000003828 vacuum filtration Methods 0.000 description 2
- ZQEXIXXJFSQPNA-UHFFFAOYSA-N 1h-imidazole-5-carbaldehyde Chemical compound O=CC1=CNC=N1 ZQEXIXXJFSQPNA-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical class [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- UKPVXFZLJKMFDC-UHFFFAOYSA-N S(O)(O)=O.C(CCC)C=1N(C(=CN1)C=O)CC1=CC=C(C(=O)O)C=C1 Chemical compound S(O)(O)=O.C(CCC)C=1N(C(=CN1)C=O)CC1=CC=C(C(=O)O)C=C1 UKPVXFZLJKMFDC-UHFFFAOYSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Lining Or Joining Of Plastics Or The Like (AREA)
- Detergent Compositions (AREA)
- Lubricants (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24643194A | 1994-05-20 | 1994-05-20 | |
| PCT/US1995/005664 WO1995032189A1 (en) | 1994-05-20 | 1995-05-04 | Intermediate for preparing a pharmaceutically active compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL317538A1 PL317538A1 (en) | 1997-04-14 |
| PL185858B1 true PL185858B1 (pl) | 2003-08-29 |
Family
ID=22930661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL95317538A PL185858B1 (pl) | 1994-05-20 | 1995-05-04 | Związek addycyjny kwasu 4-[(2-n-butylo-5-formylo-1Związek addycyjny kwasu 4-[(2-n-butylo-5-formylo-1H-imidazol-1-ilo)metylo]benzoesowego z wodorosiarcH-imidazol-1-ilo)metylo]benzoesowego z wodorosiarczynem i sposób jego wytwarzaniazynem i sposób jego wytwarzania |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5719293A (OSRAM) |
| EP (1) | EP0850225B1 (OSRAM) |
| JP (1) | JPH10500681A (OSRAM) |
| KR (1) | KR100369417B1 (OSRAM) |
| CN (1) | CN1067059C (OSRAM) |
| AT (1) | ATE247091T1 (OSRAM) |
| AU (1) | AU690270B2 (OSRAM) |
| BR (1) | BR9507668A (OSRAM) |
| CZ (1) | CZ289968B6 (OSRAM) |
| DE (1) | DE69531507T2 (OSRAM) |
| DK (1) | DK0850225T3 (OSRAM) |
| ES (1) | ES2204950T3 (OSRAM) |
| HU (1) | HU221905B1 (OSRAM) |
| MX (1) | MX9605794A (OSRAM) |
| NO (1) | NO306673B1 (OSRAM) |
| NZ (1) | NZ285588A (OSRAM) |
| PL (1) | PL185858B1 (OSRAM) |
| PT (1) | PT850225E (OSRAM) |
| WO (1) | WO1995032189A1 (OSRAM) |
| ZA (1) | ZA954053B (OSRAM) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR011125A1 (es) * | 1997-02-14 | 2000-08-02 | Smithkline Beecham Corp | Procedimiento para preparar eprosartano |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1214324A (fr) * | 1957-11-16 | 1960-04-07 | Merck Ag E | Procédé de préparation du pyridoxal et de ses dérivés à groupe aldéhyde protégé |
| US3798172A (en) * | 1969-05-26 | 1974-03-19 | Dan River Inc | Dyeing textile materials with vat and sulfur dyes and reducing agent stabilizers for same |
| JPS518934B2 (OSRAM) * | 1972-02-04 | 1976-03-22 | ||
| US4024067A (en) * | 1976-01-07 | 1977-05-17 | The United States Of America As Represented By The Secretary Of The Navy | Processes for the preparation of bis-benzoins and bis-benzils |
| JPS55104254A (en) * | 1979-02-05 | 1980-08-09 | Kuraray Co Ltd | N-substituted-alpha-cyano-3-phenoxybenzylamine |
| JPS55167274A (en) * | 1979-06-14 | 1980-12-26 | Banyu Pharmaceut Co Ltd | Forphenicine derivative and its preparation |
| JPS5671074A (en) * | 1979-11-12 | 1981-06-13 | Takeda Chem Ind Ltd | 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative |
| US5185351A (en) * | 1989-06-14 | 1993-02-09 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
| JP2568315B2 (ja) * | 1989-06-30 | 1997-01-08 | イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー | 縮合環アリール置換イミダゾール |
| JPH03112940A (ja) * | 1989-09-26 | 1991-05-14 | Nkk Corp | （±）―４―ホルミル―α―アルキルベンジルアルコール類の製造方法 |
-
1995
- 1995-05-04 DE DE69531507T patent/DE69531507T2/de not_active Expired - Lifetime
- 1995-05-04 PL PL95317538A patent/PL185858B1/pl not_active IP Right Cessation
- 1995-05-04 HU HU9603205A patent/HU221905B1/hu not_active IP Right Cessation
- 1995-05-04 CN CN95193895A patent/CN1067059C/zh not_active Expired - Fee Related
- 1995-05-04 AU AU24737/95A patent/AU690270B2/en not_active Ceased
- 1995-05-04 DK DK95919025T patent/DK0850225T3/da active
- 1995-05-04 JP JP7530315A patent/JPH10500681A/ja active Pending
- 1995-05-04 AT AT95919025T patent/ATE247091T1/de not_active IP Right Cessation
- 1995-05-04 WO PCT/US1995/005664 patent/WO1995032189A1/en not_active Ceased
- 1995-05-04 MX MX9605794A patent/MX9605794A/es not_active IP Right Cessation
- 1995-05-04 US US08/737,699 patent/US5719293A/en not_active Expired - Lifetime
- 1995-05-04 BR BR9507668A patent/BR9507668A/pt not_active Application Discontinuation
- 1995-05-04 EP EP95919025A patent/EP0850225B1/en not_active Expired - Lifetime
- 1995-05-04 NZ NZ285588A patent/NZ285588A/en not_active IP Right Cessation
- 1995-05-04 PT PT95919025T patent/PT850225E/pt unknown
- 1995-05-04 CZ CZ19963403A patent/CZ289968B6/cs not_active IP Right Cessation
- 1995-05-04 ES ES95919025T patent/ES2204950T3/es not_active Expired - Lifetime
- 1995-05-04 KR KR1019960706579A patent/KR100369417B1/ko not_active Expired - Fee Related
- 1995-05-18 ZA ZA954053A patent/ZA954053B/xx unknown
-
1996
- 1996-11-19 NO NO964921A patent/NO306673B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH10500681A (ja) | 1998-01-20 |
| NO964921D0 (no) | 1996-11-19 |
| CN1151734A (zh) | 1997-06-11 |
| BR9507668A (pt) | 1997-10-07 |
| HU221905B1 (hu) | 2003-02-28 |
| PL317538A1 (en) | 1997-04-14 |
| DK0850225T3 (da) | 2003-12-01 |
| WO1995032189A1 (en) | 1995-11-30 |
| NO964921L (no) | 1996-11-20 |
| DE69531507T2 (de) | 2004-06-17 |
| NZ285588A (en) | 1997-12-19 |
| HUT75714A (en) | 1997-05-28 |
| US5719293A (en) | 1998-02-17 |
| CN1067059C (zh) | 2001-06-13 |
| PT850225E (pt) | 2003-11-28 |
| HK1014939A1 (en) | 1999-10-08 |
| EP0850225B1 (en) | 2003-08-13 |
| ZA954053B (en) | 1996-01-19 |
| MX9605794A (es) | 1997-12-31 |
| ATE247091T1 (de) | 2003-08-15 |
| EP0850225A4 (OSRAM) | 1998-07-01 |
| EP0850225A1 (en) | 1998-07-01 |
| CZ340396A3 (en) | 1997-03-12 |
| AU690270B2 (en) | 1998-04-23 |
| DE69531507D1 (de) | 2003-09-18 |
| HU9603205D0 (en) | 1997-01-28 |
| AU2473795A (en) | 1995-12-18 |
| ES2204950T3 (es) | 2004-05-01 |
| CZ289968B6 (cs) | 2002-05-15 |
| NO306673B1 (no) | 1999-12-06 |
| KR100369417B1 (ko) | 2003-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0249308B2 (OSRAM) | ||
| EP2590943A1 (en) | Process and intermediates for preparation of an active ingredient | |
| IE51510B1 (en) | 4h-1,2,4-triazole derivatives | |
| JP2007500190A (ja) | Ｃｐｌａ２阻害剤の製法 | |
| EP1905770A1 (en) | A process for the preparation of phenyltetrazole compounds | |
| KR101050018B1 (ko) | 니트로구아니딘 유도체의 개량된 제조방법 | |
| PL185858B1 (pl) | Związek addycyjny kwasu 4-[(2-n-butylo-5-formylo-1Związek addycyjny kwasu 4-[(2-n-butylo-5-formylo-1H-imidazol-1-ilo)metylo]benzoesowego z wodorosiarcH-imidazol-1-ilo)metylo]benzoesowego z wodorosiarczynem i sposób jego wytwarzaniazynem i sposób jego wytwarzania | |
| US5064963A (en) | Process for the synthesis of n-(3-(1h-imidazol-1-yl)phenyl-4-(substituted)-2-pyrimidinamines | |
| CA2190858C (en) | Intermediate for preparing a pharmaceutically active compound | |
| EP0303478B1 (en) | Improvements in or relating to leukotriene antagonists | |
| EP0142754A2 (en) | 2-Substituted-benzoic acid imidazoles, process for preparing them and pharmaceutical compositions containing them | |
| US4647684A (en) | Process for the production of 4-amino-6,7-dimethoxy-2-[4-(furo-2-yl)-piperazin-1-yl]-quinazoline and physiologically compatible salts thereof | |
| HK1014939B (en) | Intermediate for preparing a pharmaceutically active compound | |
| US4987153A (en) | Alkylaminoamide compounds | |
| JP2681873B2 (ja) | チザニジンの製造方法 | |
| KR100303458B1 (ko) | 카복시메틸리덴사이클로헵트이미다졸유도체,그의제조방법및이화합물을함유하는치료제 | |
| EP0305085A1 (en) | Leukotriene antagonists | |
| CA2778807A1 (en) | Methods of preparing 1-(4-((1r,2s,3r)-1,2,3,4-tetrahydroxybutyl)-1h-imidazol-2-yl)ethanone | |
| KR900003882B1 (ko) | H₂항히스타민 활성을 갖는 화합물의 제조방법 | |
| NO832229L (no) | Fremgangsmaate for fremstilling av azetidinsulfonsyre | |
| WO2006134078A1 (en) | Method for obtaining benzimidazole derivatives and intermediates thereof | |
| EP0630889A1 (en) | Pharmacologically active derivatives of 2-(benzimidazol-2-yl)-1,3-diaminopropane | |
| JPS5821914B2 (ja) | イミダゾ−ルユウドウタイノ セイホウ | |
| JP2002047269A (ja) | ヘテロ環化合物の製造方法およびその中間体 | |
| JPH09323991A (ja) | 新規カルボキシメチリデンシクロヘプトイミダゾール誘導体及びその製造方法並びにこれを含有する薬剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Decisions on the lapse of the protection rights |
Effective date: 20110504 |